Phesgo billing
WebMay 2, 2024 · VI. Billing Code/Availability Information HCPCS Code: J9316 – Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg; 1 billable unit = 10 mg NDC(s): Phesgo (1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase per 15 mL) single-dose vial: 50242-0245-xx WebContact Mepco Call Us. Using your Billing Account Number, you may access your account details such as payment information, account status, remaining balance and more, 24 …
Phesgo billing
Did you know?
WebIn the PHESGO arm, the most common ARRs were injection site reaction (15%) and injection site pain (2%). Closely monitor patients during and for 30 minutes after the injection of initial dose and during and for 15 minutes following subsequent injections of maintenance dose of … WebOct 13, 2024 · DESCRIPTION. PHESGO is a combination of pertuzumab, trastuzumab, and hyaluronidase. Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). Pertuzumab is produced by recombinant DNA technology in a …
WebMar 2, 2024 · Phesgo is a cancer medicine for treating adults with ‘HER2-positive’ breast cancer (where a protein called HER2 is found on the cancer cells). It is used in combination with other cancer medicines in: patients with early breast cancer (when the cancer has not spread to other parts of the body) at high risk of coming back, after they have ... WebPhesgo is supplied as: 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase/15mL (80 mg, 40 mg, and 2,000 units/mL) of solution in a single-dose vial. …
WebNov 1, 2024 · If Phesgo is administered during pregnancy, or if a patient becomes pregnant while receiving Phesgo or within 7 months following the last dose of Phesgo, health care providers and patients should immediately report Phesgo exposure to Genentech at 1-888-835-2555. Risk Summary. Phesgo can cause fetal harm when administered to a pregnant … WebPHESGO administration can result in serious and fatal pulmonary toxicity. Discontinue PHESGO for anaphylaxis, angioedema, interstitial pneumonitis, or acute respiratory …
WebSep 15, 2024 · Description Pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo) is a fixed-dose combination of two (2) monoclonal antibodies, pertuzumab and trastuzumab, …
WebPhesgo® combined these two separate monoclonal antibodies into a single injection for use. Trastuzumab and pertuzumab are monoclonal antibodies that both target a protein called HER2 on cancer cells; however, they bind to different sites on the protein. johnson\u0027s vs minwax paste finishing waxWebPhesgo 600-600mg-20,000units vial Phesgo 1,200-600mg-30,000units vial Directions for use: Dose: Quantity: Duration of therapy: ... Prescriber’s office stock (billing on a medical claim form) Other (please specify): Retail pharmacy Home Health / Home Infusion vendor ** Cigna’s nationally preferred specialty pharmacy johnson\u0027s walleye retreatWebNov 16, 2024 · When administered with PHESGO, the recommended initial dose of docetaxel is 75 mg/m 2 administered as an intravenous infusion. The dose may be escalated to 100 mg/m 2 administered every 3 weeks if the initial dose is well tolerated. Administer PHESGO until disease progression or unmanageable toxicity, whichever occurs first. how to give yourself experience in unturnedWebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body … johnson\u0027s waterfowl hatchery ducksWebThe NDC Packaged Code 50242-245-01 is assigned to a package of 1 vial, single-dose in 1 carton / 15 ml in 1 vial, single-dose of Phesgo, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form. The following table has all the important details about this ... johnson\u0027s websiteWebPHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive). johnson\u0027s webWebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-HER2 therapy or chemotherapy for metastatic breast cancer. What are the most serious side effects of PHESGO? johnson\u0027s water based gloss paint